Sunshine Biopharma (SBFMW) Cash & Equivalents Growth (1y) (2011 - 2026)
Sunshine Biopharma (SBFMW) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 120.45% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 12.78% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -32.64% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 37.30% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -50.92% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -12.11% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -12.07% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -46.88% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 31.24% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | -14.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.91% |
| Dec 31, 2025 | -5.81% |
| Sep 30, 2025 | -23.76% |
| Jun 30, 2025 | -10.45% |
| Mar 31, 2025 | -53.40% |
| Dec 31, 2024 | -40.55% |
| Sep 30, 2024 | -35.23% |
| Jun 30, 2024 | -41.67% |
| Mar 31, 2024 | -9.64% |
| Dec 31, 2023 | -25.35% |
| Sep 30, 2023 | -53.53% |
| Jun 30, 2023 | -52.72% |
| Mar 31, 2023 | 46.42% |
| Dec 31, 2022 | 967.22% |
| Sep 30, 2022 | 1,599.31% |
| Jun 30, 2022 | 2,304.93% |
| Mar 31, 2022 | 633.48% |
| Dec 31, 2021 | 106.61% |
| Sep 30, 2021 | 388.35% |
| Jun 30, 2021 | 1,927.14% |